DIA: Driving Insights to Action
Science:Life Sciences
Dr. J. Vijay Venkatraman, India Regional Editor for Global Forum and Managing Director & CEO for Oviya MedSafe Private Limited (India), discusses the Pharmacovigilance Guidance Document for Marketing Authorization Holders of Pharmaceutical Products in India, which came into effect January 2018, and the Pharmacovigilance Programme of India (PvPI).
More Episodes
Oligonucleotides Driving Personalized Medicine Research
2017-08-24
250
2017-08-24
250
Celebrating 150 Years with Better Care for Canadians
2017-08-21
153
2017-08-21
153
Future Science & Drug Review: FDA Closing the Gap
2017-08-09
378
2017-08-09
378
HHS Final Rule: Good Data Shared Well Leads to Great Science
2017-07-26
214
2017-07-26
214
Patient Partners: Power That Rests in Us All
2017-07-26
195
2017-07-26
195
Technology & Data Driving Europe’s ClinOps Forward
2017-07-25
225
2017-07-25
225
CFDA Joins ICH, Seeks Public Comment on Further Reforms
2017-06-29
311
2017-06-29
311
New DIA Forum to Align Regulatory & ClinOps Expectations
2017-06-29
196
2017-06-29
196
Different Roots, Shared Fruits: FDA-EMA Collaboration
2017-06-08
263
2017-06-08
263
RWE: Bridge Between Clinical Research & Practice?
2017-06-08
208
2017-06-08
208
Is Drug Repurposing Really As Promising As It Seems?
2017-05-25
188
2017-05-25
188
New China-Denmark Food & Drug Regulatory Cooperation Centre
2017-05-24
218
2017-05-24
218
ABPI Sees Brexit as One Game of Two Halves
2017-05-18
228
2017-05-18
228
Europe’s IMI Helps Drive New R&D and Access Models
2017-05-12
147
2017-05-12
147
Lack of Access Can Lock Patients in “Disease of Despair”
2017-05-12
142
2017-05-12
142
Can We “Pay for Results” to Sustain Innovation?
2017-05-12
122
2017-05-12
122
Uncertainty is Certain: Pandemic Vaccine Preparedness
2017-05-11
137
2017-05-11
137
Where and How to Bridge the EU Biotech Funding Gap
2017-05-08
111
2017-05-08
111
Get this podcast on your
phone, FREE
